Skip to Content

Tiazac

In the US, Tiazac (diltiazem systemic) is a member of the following drug classes: calcium channel blocking agents, group IV antiarrhythmics and is used to treat Angina Pectoris Prophylaxis, Atrial Fibrillation, Atrial Flutter, Heart Failure, High Blood Pressure, Raynaud's Syndrome and Supraventricular Tachycardia.

US matches:

Ingredient matches for Tiazac

Diltiazem

Diltiazem hydrochloride (a derivative of Diltiazem) is reported as an ingredient of Tiazac in the following countries:

  • Canada
  • United States

Pioglitazone

Pioglitazone is reported as an ingredient of Tiazac in the following countries:

  • Peru

International Drug Name Search

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide